The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies have been employed to antibody titer, such as process parameter optimization, genetic engineering, and implementation of perfusion systems. Fine-tuning growth param